Cargando…
Personalized health care beyond oncology: new indications for immunoassay‐based companion diagnostics
Personalized health care (PHC) is an evolving field of medicine aimed at providing the right therapy to the right patient at the right time. This approach often incorporates the use of companion diagnostics (CDx) assays that provide information essential for the safe and effective use of the corresp...
Autores principales: | Batrla, Richard, Jordan, Bruce W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744740/ https://www.ncbi.nlm.nih.gov/pubmed/25866164 http://dx.doi.org/10.1111/nyas.12754 |
Ejemplares similares
-
The Clinical and Health Economic Value of Clinical Laboratory Diagnostics
por: Jordan, Bruce, et al.
Publicado: (2015) -
Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
por: Van Heertum, Ronald L, et al.
Publicado: (2015) -
Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer
por: Plönes, Till, et al.
Publicado: (2016) -
How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments
por: Gomez Montero, Melissa, et al.
Publicado: (2022) -
Companion Diagnostics: State of the Art and New
Regulations
por: Valla, Vasiliki, et al.
Publicado: (2021)